A Study of CM512 in Subjects With Moderate-to-Severe Chronic Obstructive Pulmonary Disease

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase II Study to Explore the Efficacy and Safety of CM512 Injection in Adults with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Epistemonikos ID: 69beeac4a99979edd02c331825eb461813e1e060
First added on: May 21, 2025